These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19903452)

  • 1. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
    Kim HK; Joe YA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
    Su L; Xu X; Zhao H; Gu Q; Zou H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
    Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kringle domain of tissue-type plasminogen activator inhibits extracellular matrix-induced adhesion and migration of endothelial cells.
    Lee BH; Kim HK; Joe YA
    Biosci Biotechnol Biochem; 2008 Sep; 72(9):2303-8. PubMed ID: 18776698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
    Lee SB; Oh HK; Kim HK; Joe YA
    Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
    Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
    J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kringle domain of tissue-type plasminogen activator inhibits in vivo tumor growth.
    Shim BS; Kang BH; Hong YK; Kim HK; Lee IH; Lee SY; Lee YJ; Lee SK; Joe YA
    Biochem Biophys Res Commun; 2005 Feb; 327(4):1155-62. PubMed ID: 15652516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
    Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
    Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimigratory effect of TK1-2 is mediated in part by interfering with integrin alpha2beta1.
    Kim HK; Oh DS; Lee SB; Ha JM; Joe YA
    Mol Cancer Ther; 2008 Jul; 7(7):2133-41. PubMed ID: 18645023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
    Juarez JC; Guan X; Shipulina NV; Plunkett ML; Parry GC; Shaw DE; Zhang JC; Rabbani SA; McCrae KR; Mazar AP; Morgan WT; Doñate F
    Cancer Res; 2002 Sep; 62(18):5344-50. PubMed ID: 12235005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2.
    Carroll VA; Nikitenko LL; Bicknell R; Harris AL
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):736-41. PubMed ID: 15692103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent anti-tumor and prolonged survival effects of E. coli-derived non-glycosylated kringle domain of tissue-type plasminogen activator.
    Kang BH; Shim BS; Lee SY; Lee SK; Hong YK; Joe YA
    Int J Oncol; 2006 Feb; 28(2):361-7. PubMed ID: 16391790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kringle 5 peptide-albumin conjugates with anti-migratory activity.
    Léger R; Benquet C; Huang X; Quraishi O; van Wyk P; Bridon D
    Bioorg Med Chem Lett; 2004 Feb; 14(4):841-5. PubMed ID: 15012978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel integrin alpha5beta1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor.
    Kim EY; Bang JY; Chang SI; Kang IC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1288-93. PubMed ID: 18996355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.